ALZN
Price
$0.22
Change
-$0.01 (-4.35%)
Updated
Sep 22, 6:59 PM EST
One day until earnings call
MDGL
Price
$153.34
Change
-$6.17 (-3.87%)
Updated
Sep 22, 6:59 PM EST
39 days until earnings call

ALZN vs MDGL ᐉ Comparison: Which is Better to Invest?

Header iconALZN vs MDGL Comparison
Open Charts ALZN vs MDGLBanner chart's image
Alzamend Neuro
Price$0.22
Change-$0.01 (-4.35%)
Volume$84.91K
CapitalizationN/A
Madrigal Pharmaceuticals
Price$153.34
Change-$6.17 (-3.87%)
Volume$169.81K
CapitalizationN/A
View a ticker or compare two or three
ALZN vs MDGL Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ALZN vs. MDGL commentary
Sep 24, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a Hold and MDGL is a Hold.

COMPARISON
Comparison
Sep 24, 2023
Stock price -- (ALZN: $0.22 vs. MDGL: $153.34)
Brand notoriety: ALZN and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 87% vs. MDGL: 118%
Market capitalization -- ALZN: $21.32M vs. MDGL: $2.83B
ALZN [@Biotechnology] is valued at $21.32M. MDGL’s [@Biotechnology] market capitalization is $2.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $410.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 0 green FA rating(s).

  • ALZN’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALZN and MDGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 5 TA indicator(s) are bullish while MDGL’s TA Score has 4 bullish TA indicator(s).

  • ALZN’s TA Score: 5 bullish, 2 bearish.
  • MDGL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ALZN is a better buy in the short-term than MDGL.

Price Growth

ALZN (@Biotechnology) experienced а -8.37% price change this week, while MDGL (@Biotechnology) price change was -12.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.79%. For the same industry, the average monthly price growth was +32.38%, and the average quarterly price growth was +31.88%.

Reported Earning Dates

ALZN is expected to report earnings on Jan 03, 2024.

MDGL is expected to report earnings on Nov 02, 2023.

Industries' Descriptions

@Biotechnology (-4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALZN with price predictions.
OPEN
A.I.dvisor published
a Summary for MDGL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MDGL($2.83B) has a higher market cap than ALZN($21.3M). MDGL YTD gains are higher at: -47.170 vs. ALZN (-61.073). ALZN has higher annual earnings (EBITDA): -15.33M vs. MDGL (-320.88M). MDGL has more cash in the bank: 298M vs. ALZN (1.7M). ALZN has less debt than MDGL: ALZN (345K) vs MDGL (99.7M). ALZN (0) and MDGL (0) have equivalent revenues.
ALZNMDGLALZN / MDGL
Capitalization21.3M2.83B1%
EBITDA-15.33M-320.88M5%
Gain YTD-61.073-47.170129%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.7M298M1%
Total Debt345K99.7M0%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALZNMDGL
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 19 days ago
88%
Bullish Trend 16 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RZB25.450.11
+0.43%
Reinsurance Group of America
SIMS32.10-0.04
-0.12%
SPDR® S&P Kensho Intelligent Strctr ETF
JANW28.91-0.04
-0.13%
AllianzIM US Large Cap Buffer20 Jan ETF
IYZ21.70-0.10
-0.46%
iShares US Telecommunications ETF
FSTA43.44-0.23
-0.53%
Fidelity® MSCI Consumer Staples ETF

ALZN and

Correlation & Price change

A.I.dvisor tells us that ALZN and AXON have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALZN and AXON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
-3.93%
AXON - ALZN
30%
Poorly correlated
-0.36%
MDGL - ALZN
29%
Poorly correlated
-3.87%
AVRO - ALZN
29%
Poorly correlated
-0.65%
SRNEQ - ALZN
28%
Poorly correlated
-2.54%
ITRM - ALZN
28%
Poorly correlated
-0.37%
More

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with SGMO. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then SGMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
-3.87%
SGMO - MDGL
62%
Loosely correlated
-4.82%
VKTX - MDGL
62%
Loosely correlated
-3.23%
IBRX - MDGL
62%
Loosely correlated
+0.92%
KA - MDGL
62%
Loosely correlated
-3.77%
RVMD - MDGL
61%
Loosely correlated
-1.57%
More